Page 60 - ARNM-2-1

Advances in Radiotherapy
& Nuclear Medicine Symmetrical bilateral extranodal recurrence in FL

doi: 10.1148/rg.301095088 15. Alnouby A, Ibraheem Nasr IM, Ali I, Rezk M. F-18 FDG
PET-CT versus contrast enhanced CT in detection of extra
12. Fardin S, Gholami S, Werner TJ, Rook AH, Alavi A. Imaging nodal involvement in patients with lymphoma. Indian J Nucl
evaluation of cutaneous lymphoma using functional and Med. 2018;33(3):183-189.
structural imaging. In: Imaging in Dermatology. Netherlands:
Elsevier, 2016. p. 485-490. doi: 10.4103/ijnm.IJNM_47_18
doi: 10.1016/B978-0-12-802838-4.00035-2 16. Ferrer A, López-Guillermo A, Montoto S, Estrach T,
Colomo L, Montserrat E. Successful treatment of isolated
13. Fueger BJ, Yeom K, Czernin J, Sayre JW, Phelps ME, Allen- cutaneous relapse of follicular lymphoma with rituximab.
Auerbach MS. Comparison of CT, PET, and PET/CT for Ann Hematol. 2001;80(8):479-481.
staging of patients with indolent non-hodgkin’s lymphoma.
Mol Imaging Biol. 2009;11(4):269-274. doi: 10.1007/s002770100314
doi: 10.1007/s11307-009-0200-9 17. Trotman J, Pettitt AR. Is it time for pet-guided therapy in
follicular lymphoma? Blood 2022;139(11):1631-1641.
14. Mandava A, Koppula V, Wortsman X, Catalano O,
Alfageme F. The clinical value of imaging in primary doi: 10.1182/blood.2020008243
cutaneous lymphomas: Role of high resolution ultrasound 18. Gallamini A, Zwarthoed C. Interim FDG-PET imaging in
and PET-CT. Br J Radiol. 2019;92(1095):20180904. lymphoma. Semin Nucl Med. 2018;48(1):17-27.
doi: 10.1259/bjr.20180904 doi: 10.1053/j.semnuclmed.2017.09.002

Volume 2 Issue 1 (2024) 5 https://doi.org/10.36922/arnm.2828